Cerebral palsy
Cerebral Palsy (CP) is a permanent physical condition that affects movement. Movements can be unpredictable, muscles can be stiff or tight and in some cases people can have shaky movements or tremors. People with cerebral palsy may have seizures and other impairments affecting their speech, vision, hearing and/or intellect. Don’t be mistaken, Cerebral Palsy is not an intellectual disability. What may sometimes appear as an incapable child, they have intelligent minds. It somewhat seems unfair. Cerebral palsy, except in its mildest forms, can be seen in the first 12-18 months of life. It presents when children fail to reach movement milestones. Babies most at risk of cerebral palsy are those born prematurely or with low birth weight. In Australia it is estimated that a child is born with cerebral palsy every 15 hours. Worldwide, the incidence is the same 1 in 400 births. There is no pre-birth test and no known cure. For most, the cause is unknown.
Ce
Cerebral palsy cannot be cured. Standard treatments include drugs, mechanical aids, physical therapy, behavioural therapy, occupational therapy and speech therapy. All these approaches are focused at helping the patient overcome developmental disabilities or learn new ways to accomplish difficult tasks. In Germany, treatment differs from standard methods because it attacks the root cause of CP inside the brain. Stem cell therapy is a drug-free alternative focused on affecting physical changes in the brain that can improve a child's quality of life.
Almost 70% of the cerebral palsy patients treated with stem cells at the Germany Centre show improvement.
Follow up statistics from 100 cerebral palsy patients completed in March 2010 show that close to 67% experienced improvements after stem cell therapy. The type of improvements reported include: decreased spasticity; better coordination; improved motor function, improved posture stability; better cognition resulting in communication improvements; gaining the ability to sit, stand or even walk unassisted.
Improved speech was observed in 56% of patients. 43% reported a decrease or even absence of epileptic seizures following treatment.
